Patents by Inventor Nira Bloom

Nira Bloom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8859745
    Abstract: An isolated polynucleotide functional as a promoter in eukaryotic cells is disclosed. The isolated polynucleotide includes an endothelial specific enhancer element as detailed herein. Further disclosed is a method of expressing a nucleic acid sequence of interest in endothelial cells.
    Type: Grant
    Filed: June 3, 2009
    Date of Patent: October 14, 2014
    Assignee: Vascular Biogenics Ltd.
    Inventors: Dror Harats, Eyal Breitbart, Nira Bloom
  • Patent number: 8859747
    Abstract: An isolated polynucleotide functional as a promoter in eukaryotic cells is disclosed. The isolated polynucleotide includes an endothelial specific enhancer element as detailed herein. Further disclosed is a method of expressing a nucleic acid sequence of interest in endothelial cells.
    Type: Grant
    Filed: March 13, 2013
    Date of Patent: October 14, 2014
    Assignee: Vascular Biogenics Ltd.
    Inventors: Dror Harats, Eyal Breitbart, Nira Bloom
  • Patent number: 8846401
    Abstract: An isolated polynucleotide functional as a promoter in eukaryotic cells is disclosed. The isolated polynucleotide includes an endothelial specific enhancer element as detailed herein. Further disclosed is a method of expressing a nucleic acid sequence of interest in endothelial cells.
    Type: Grant
    Filed: April 24, 2012
    Date of Patent: September 30, 2014
    Assignee: Vascular Biogenics Ltd.
    Inventors: Dror Harats, Eyal Breitbart, Nira Bloom
  • Publication number: 20130296404
    Abstract: An isolated polynucleotide functional as a promoter in eukaryotic cells is disclosed. The isolated polynucleotide includes an endothelial specific enhancer element as detailed herein. Further disclosed is a method of expressing a nucleic acid sequence of interest in endothelial cells.
    Type: Application
    Filed: March 13, 2013
    Publication date: November 7, 2013
    Inventors: Dror HARATS, Eyal Breitbart, Nira Bloom
  • Publication number: 20120201790
    Abstract: An isolated polynucleotide functional as a promoter in eukaryotic cells is disclosed. The isolated polynucleotide includes an endothelial specific enhancer element as detailed herein. Further disclosed is a method of expressing a nucleic acid sequence of interest in endothelial cells.
    Type: Application
    Filed: April 24, 2012
    Publication date: August 9, 2012
    Applicant: Vascular Biogenics Ltd.
    Inventors: Dror HARATS, Eyal Breitbart, Nira Bloom
  • Publication number: 20110201677
    Abstract: An isolated polynucleotide functional as a promoter in eukaryotic cells is disclosed. The isolated polynucleotide includes an endothelial specific enhancer element as detailed herein. Further disclosed is a method of expressing a nucleic acid sequence of interest in endothelial cells.
    Type: Application
    Filed: April 27, 2011
    Publication date: August 18, 2011
    Applicant: Vascular Biogenics Ltd.
    Inventors: Dror HARATS, Eyal Breitbart, Nira Bloom
  • Publication number: 20090326052
    Abstract: An isolated polynucleotide functional as a promoter in eukaryotic cells is disclosed. The isolated polynucleotide includes an endothelial specific enhancer element as detailed herein. Further disclosed is a method of expressing a nucleic acid sequence of interest in endothelial cells.
    Type: Application
    Filed: June 3, 2009
    Publication date: December 31, 2009
    Applicant: Vascular Biogenics Ltd.
    Inventors: Dror Harats, Eyal Breitbart, Nira Bloom
  • Patent number: 7579327
    Abstract: An isolated polynucleotide functional as a promoter in eukaryotic cells is disclosed. The isolated polynucleotide includes an endothelial specific enhancer element as detailed herein. Further disclosed is a method of expressing a nucleic acid sequence of interest in endothelial cells.
    Type: Grant
    Filed: October 29, 2004
    Date of Patent: August 25, 2009
    Assignee: Vascular Biogenics Ltd.
    Inventors: Dror Harats, Eyal Breitbart, Nira Bloom